Healthy Source: Appointed Zhang Qinglei as Vice President of the Company

On January 16, Healthsource announced that the board of directors approved the appointment of Zhang Qinglei as the vice president of the company. He will be responsible for all aspects of the company's pharmaceutical regulatory affairs, and will promote the clinical research and new drug application of the company's innovative drug product pipeline. His term will be from the date of the board of directors' approval to the expiration of the ninth term of the company's board of directors.